Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Consistency year to year matters for goals like retirement or college funding. This primer outlines how to assess return stability across periods.
24,424 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
AI-driven momentum puts Apple on a path to a potential $6 trillion valuation, as investors weigh WWDC 2026 plans and ...
Galaxy Research analyst Alex Thorn lifts the odds of the CLARITY Act becoming law in 2026 to 75%, citing a pivotal Se...
Harvard's Faculty of Arts and Sciences approved a move to limit A grades for undergraduates, signaling a major bid to...
Regulators and banks frame XRP's path as traders debate a remote target. This report lays out what would be required ...
A caller revealed a concealed debt load of $650,000 on a national investing show. The incident underscores growing fi...
BitGo and Galaxy Digital continue their in-court battle over a failed $1.2 billion merger, with BitGo seeking damages...
A broad study shows younger adults delaying key life events, pressuring insurers to rethink offerings as 'living bene...
A potential energy shock could ripple through retail margins and consumer demand this summer. This guide explains wha...
Warren Buffett's long-held Coca-Cola stake offers a blueprint for patient investing. Learn how durable moats, consist...
Trump’s latest Walter Reed visit lasted over three hours, renewing questions about the president’s health and its imp...
Oil trades near $96 a barrel as investors parse OPEC plans and demand signals. The current price 2026 landscape remai...